InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.670
+0.060 (3.73%)
May 12, 2025, 4:00 PM - Market closed
InflaRx Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for InflaRx stock ranges from a low of $6.00 to a high of $10. The average price target of $8.50 forecasts a 408.98% increase in the stock price over the next year.
Price Target: $8.50 (+408.98%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for InflaRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $6 | Buy | Initiates | $6 | +259.28% | May 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +498.80% | Apr 29, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +498.80% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +379.04% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +379.04% | Mar 7, 2025 |
Financial Forecast
Revenue This Year
342.72K
from 165.79K
Increased by 106.72%
Revenue Next Year
571.97K
from 342.72K
Increased by 66.89%
EPS This Year
-0.66
from -0.78
EPS Next Year
-0.62
from -0.66
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 576,450 | 1.1M | 162.1M | ||
| Avg | 342,720 | 571,965 | 61.8M | ||
| Low | 196,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 247.7% | 215.1% | 28,235.6% | ||
| Avg | 106.7% | 66.9% | 10,712.5% | ||
| Low | 18.2% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.48 | -0.26 | 0.22 | ||
| Avg | -0.66 | -0.62 | -0.37 | ||
| Low | -0.74 | -0.83 | -0.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.